Anti Microbial
Resistance Pipeline
Empowering engineered phages with CRISPR to modify microbiome for better medicine
Engineering phages for precision delivery of DNA payloads to target bacteria
Innovating DNA payloads by combining CRISPR & synthetic biology science
Controlling traits of target bacteria by customizing its genetic signature
The gut microbiome is made up of trillions of bacteria, fungi, and other microbes. The microbiome is associated with multiple indications such as gut inflammation, oncology, autoimmune diseases, neurological disorders, metabolic syndrome, and more.
Extensive basic research in the field leads to thousands of high impact publications each year, and an immense growth in registered patents.
The rising interest in the microbiome field is evident with a growing number of companies, investments, big pharma collaborations, and multiple microbiome-associated clinical trials.
Our dedicated founders, scientific team and investors are committed to develop life saving therapeutics